Literature DB >> 26102331

Inhibition of amyloid fibrillation and cytotoxicity of lysozyme fibrillation products by polyphenols.

Sajad Shariatizi1, Ali Akbar Meratan2, Atiyeh Ghasemi1, Mohsen Nemat-Gorgani3.   

Abstract

An increasing number of studies conducted under in vitro and in vivo conditions, have concluded that polyphenols, compounds frequently occurring in many herbs with antioxidant properties, prevent and reverse amyloid fibril formation. However, the mechanisms by which these natural products modulate the protein aggregation process are poorly understood. Herein, a range of techniques including thioflavin T (ThT) and ANS fluorescence assays, electron microscopy and circular dichroism have been employed to determine the efficacy of rosmarinic acid (RA) and resveratrol (Res) on the inhibition/reversion of fibrillogenesis and hindering cytotoxicity induced by protofibrils and amyloid fibrils of hen egg white lysozyme (HEWL). Results demonstrated that both polyphenols effectively inhibit fibrillogenesis and destabilize preformed fibrils of HEWL in a concentration-dependent manner. Cytotoxicity protection on PC12 cells was also observed using the MTT assay, ROS production assay, and phase-contrast microscopy. It is suggested that the mechanism underlying the inhibitory effects of RA and Res is to prevent hydrophobic interactions between HEWL amyloidogenic prefibrillar species, although additional studies is needed to elucidate the detailed mechanisms involved. A combination of antioxidative and anti-amyloidogenic properties of these molecules may provide them with the described neuroprotective capacities.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-amyloidogenic; Fibrillation products cytotoxicity; Polyphenol

Mesh:

Substances:

Year:  2015        PMID: 26102331     DOI: 10.1016/j.ijbiomac.2015.06.030

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  8 in total

1.  Modulating protein amyloid aggregation with nanomaterials.

Authors:  Bo Wang; Emily H Pilkington; Yunxiang Sun; Thomas P Davis; Pu Chun Ke; Feng Ding
Journal:  Environ Sci Nano       Date:  2017-07-28

2.  Bivalent metal ions induce formation of α-synuclein fibril polymorphs with different cytotoxicities.

Authors:  Deyhim Atarod; Fatemeh Mamashli; Atiyeh Ghasemi; Faezeh Moosavi-Movahedi; Mitra Pirhaghi; Hadi Nedaei; Vladimir Muronetz; Thomas Haertlé; Jörg Tatzelt; Gholamhossein Riazi; Ali Akbar Saboury
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

Review 3.  Inhibition of protein misfolding and aggregation by natural phenolic compounds.

Authors:  Zohra Dhouafli; Karina Cuanalo-Contreras; El Akrem Hayouni; Charles E Mays; Claudio Soto; Ines Moreno-Gonzalez
Journal:  Cell Mol Life Sci       Date:  2018-07-20       Impact factor: 9.261

4.  Vitamin k3 inhibits protein aggregation: Implication in the treatment of amyloid diseases.

Authors:  Parvez Alam; Sumit Kumar Chaturvedi; Mohammad Khursheed Siddiqi; Ravi Kant Rajpoot; Mohd Rehan Ajmal; Masihuz Zaman; Rizwan Hasan Khan
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

5.  Oxidized epigallocatechin gallate inhibited lysozyme fibrillation more strongly than the native form.

Authors:  Ting-Ting An; Shuang Feng; Cheng-Ming Zeng
Journal:  Redox Biol       Date:  2016-12-21       Impact factor: 11.799

6.  Inhibition of HEWL fibril formation by taxifolin: Mechanism of action.

Authors:  Mohsen Mahdavimehr; Ali Akbar Meratan; Maryam Ghobeh; Atiyeh Ghasemi; Ali Akbar Saboury; Mohsen Nemat-Gorgani
Journal:  PLoS One       Date:  2017-11-13       Impact factor: 3.240

7.  Rosmarinic Acid and Melissa officinalis Extracts Differently Affect Glioblastoma Cells.

Authors:  Kristina Ramanauskiene; Raimondas Raudonis; Daiva Majiene
Journal:  Oxid Med Cell Longev       Date:  2016-09-05       Impact factor: 6.543

8.  Inhibition of Protein Aggregation by Several Antioxidants.

Authors:  Samra Hasanbašić; Alma Jahić; Selma Berbić; Magda Tušek Žnidarič; Eva Žerovnik
Journal:  Oxid Med Cell Longev       Date:  2018-03-25       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.